NCT00396279 2022-11-08
Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone
Amgen
Phase 2 Completed
Amgen
University Health Network, Toronto
Duke University
University of Washington
University of Minnesota
Emory University